Our dementia prevention program is grounded in the conviction that the most effective care begins long before symptoms do. We are dedicated to identifying and addressing dementia risk well before significant cognitive decline occurs, as many risk factors for cognitive decline are reversible, especially when addressed in midlife.
A 2024 Lancet Commission report identified 14 modifiable risk factors that collectively account for an estimated 45% of dementia cases worldwide. Current research suggests that a substantial share of risk may be delayed or prevented through timely intervention, especially when addressed in midlife. These factors span the full life course and include hearing loss, vision loss, high LDL cholesterol, hypertension, obesity, diabetes, physical inactivity, smoking, excessive alcohol use, traumatic brain injury, depression, social isolation, lower educational attainment, and exposure to air pollution.
Beyond lifestyle and metabolic factors, we use several tools to build a full picture of each patient's brain health. Neuropsychological testing measures memory, attention, and other cognitive skills in detail. Blood-based biomarker testing can detect early signs of Alzheimer's-related changes before symptoms appear. Genetic counseling helps patients understand inherited risk, including APOE status, and what it does and doesn't mean for their future. Imaging studies, such as MRI, give us a direct look at brain structure and any changes over time. We also review each patient's full lab work, current medications, and vaccine history, since all three can meaningfully affect dementia risk. Together, these tools let us build a risk profile that's specific to each patient, as well as a proactive plan to reduce that risk.
This service is intended for individuals who wish to understand and proactively manage their long-term brain health, including those with a family history of dementia, a genetic or clinical predisposition toward cognitive decline, or simply a desire to safeguard their cognitive future before signs of change emerge.
Through comprehensive cognitive screening, detailed risk factor assessment, blood-based biomarker testing, and a nuanced understanding of how sleep, metabolic health, cardiovascular function, and lifestyle collectively shape long-term brain health, we work closely with each patient to develop a personalized, evidence-informed plan aimed at preserving cognitive function over time.
New Clients: $750
Returning Clients: $450
Prior to your appointment date, you will receive a few questionnaires to complete to help get the conversation started before we start your in-office risk assessment.
Baseline neuropsychological screening
Hearing assessment
Blood-based biomarker testing for Alzheimer’s disease: P-tau217 is a blood based biomarker that is highly accurate for predicting the presence of an abnormal amount of amyloid plaques in individuals over the age of 50. (https://precivityad.com/).
Genetic testing for Alzheimer’s disease
Dementia risk factor identification
Substance use discussion
Abdominal girth measurements
Mental health assessment
Family history discussion
Lifestyle review (exercise, sleep, relationships, stress management, lifelong learning, mindfulness, nutrition, purpose, and service)
Medication and supplement review
Brain imaging review
Review of recent bloodwork
Next, we help you modify your risk factors.
Nutrition intentions
Medical weight management with semaglutide or tirzepatide
Optimizing your exercise plan
Addressing hearing loss
Setting metabolic and abdominal girth goals
Medication and supplement counseling
Sleep counseling as needed
Lifelong learning plan
Relational matters
Vaccine review
Q/A: Which substances add more risk?
General health review and goal-setting
Livingston G, et al. Lancet. 2024;404:572-628. https://doi.org/10.1016/S0140-6736(24)01296-0
Preventive Neurology
Our Cognitive Longevity Program begins with understanding your risk.